Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2000
08/31/2000CA2363118A1 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d
08/31/2000CA2363095A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds
08/31/2000CA2363048A1 Treatment of trauma
08/31/2000CA2326690A1 The process for manufacturing topical ophthalmic preparations without systemic effects
08/30/2000EP1031835A1 Diagnostic, prognostic, and therapeutic methods for solid non-lymphoid tumors and their metastases.
08/30/2000EP1031585A2 Method of preparation of aqueous dispersions from copolymers of hydrophile and hydrophobe monomers, these copolymers and their uses
08/30/2000EP1031578A2 High purity albumin production by a multistep process
08/30/2000EP1031353A1 Antimycotic compositions
08/30/2000EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers
08/30/2000EP1030863A1 A method for attaching polyethylene glycol to macromolecules
08/30/2000EP1030734A1 Encapsulate of active material in alginate matrix
08/30/2000EP1030697A2 Biodegradable polymer scaffold
08/30/2000EP1030689A1 Complex between carrageenan and a water soluble drug having a specific granulometry and relative controlled release pharmaceutical compositions
08/30/2000EP1030688A1 Method for decreasing self-association of polypeptides
08/30/2000EP1030687A2 Cosmetic or dermopharmaceutical composition in the form of beads and methods for preparing same
08/30/2000EP1030676A1 Bonding of cartilaginous matrices using isolated chondrocytes
08/30/2000EP1030668A1 Penetration enhancing and irritation reducing systems
08/30/2000EP1030664A1 Pharmaceutical compositions containing zafirlukast
08/30/2000EP1030660A1 A transdermal drug delivery system for anti-inflammatory analgesic agent comprising diclofenac diethylammonium salt, and the manufacturing method thereof
08/30/2000EP1030657A1 Prolamin-plant polar lipid combination, preparation method and applications
08/30/2000EP1030656A1 Administering active substances by using the capsid produced out of the polyoma virus vp1 protein
08/30/2000EP1030655A1 Low temperature coatings
08/30/2000EP1030654A1 Omeprazole formulation
08/30/2000EP1030651A1 Novel oral dosage form for carvedilol
08/30/2000EP1030566A1 Use of liquid carbohydrate fermentation product in foods
08/30/2000EP1030547A1 Methods for preventing and treating bacterial infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients
08/30/2000EP0869714B1 Method for the control of infestations of honeybee colonies
08/30/2000EP0831912A4 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
08/30/2000EP0759937B1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus
08/30/2000EP0730493B1 Use of a polymer material based on modified hydrocolloids as encapsulating material
08/30/2000EP0573605B1 Preparation of factor ix
08/30/2000CN1265029A Pharmaceutical compsn. having two coating layers
08/30/2000CN1264712A Method for preparing copolymer water dispersing body by hydrophilous and hydrophobic monomer, and obtained copolymer therefrom and application
08/30/2000CN1055864C Method of preparing contract media
08/29/2000US6110926 Storage stable aqueous solution of naloxone hydrochloride mixed with a polyhydric alcohol; for opioid addiction testing
08/29/2000US6110921 Administering to mammal a sustained-release microparticle comprising antipsychotic agent in biodegradable polymer matrix
08/29/2000US6110905 Long-acting oxytetracycline composition
08/29/2000US6110900 Nucleic acid ligands
08/29/2000US6110692 Receptor for underivatized aqueous soluble β(1-3)-glucan
08/29/2000US6110506 Synthesizing a dihydroxy aluminum sodium carbonate, isolating the undried dihydroxyaluminum sodium carbonate and mixing with water and a polyol selected from glycerol, mannitol, maltodextrin and frusctose, forming a suspension, then drying
08/29/2000US6110505 Translucent antacid suspension containing co-dried dihydroxy aluminum sodium carbonate
08/29/2000US6110503 Preparation of biodegradable, biocompatible microparticles containing a biologically active agent
08/29/2000US6110498 A wicking agent which provides enhanced flow channels for the drug and which has been made into its solubilized form by solubilizer, while still within the tablet, thus, the drug is delivered out through passages in the coating wall by osmosis
08/29/2000US6110497 Pharmaceutical formulations
08/29/2000US6110485 Includes a therapeutical agent and retanoid along with a carrier sized for insertion into eye tissue in which the systemic release of a therapeutical agent is desired for providing sustained or controlled release of the drug
08/29/2000US6110453 Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
08/29/2000US6110443 Dissolving in water and ultrasonic imaging and microbubble with surfactants of phospholipid and stabilizers
08/29/2000CA2065210C Controlled release matrix for pharmaceuticals
08/29/2000CA2010164C Anthracycline immunoconjugates having a novel linker and methods for their production
08/24/2000WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
08/24/2000WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof
08/24/2000WO2000048643A1 Biodegradable, injectable oligomer-polymer composition
08/24/2000WO2000048638A2 Multi-mutant diphtheria toxin vaccines
08/24/2000WO2000048637A1 Painless and tissue-conserving injection of medicaments
08/24/2000WO2000048636A1 Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients
08/24/2000WO2000048635A1 Novel albumin-free factor viii formulations
08/24/2000WO2000048634A1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism
08/24/2000WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS
08/24/2000WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
08/24/2000WO2000048621A2 Methods and compositions for regulating protein-protein interactions
08/24/2000WO2000048607A1 Directly compressible matrix for controlled release of single daily doses of clarithromycin
08/24/2000WO2000048598A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
08/24/2000WO2000048596A1 Soluble forms of amoxicillin and treatment of animals
08/24/2000WO2000048590A1 Substituted stilbene compounds with vascular damaging activity
08/24/2000WO2000048588A1 Pharmaceutical topical compositions containing a non-steroidal antiinflammatory drug
08/24/2000WO2000048587A1 Combinations of formoterol and fluticasone propionate for asthma
08/24/2000WO2000048585A1 Effervescent laxatives
08/24/2000WO2000048580A1 Sheet-form adhesive preparation
08/24/2000WO2000048579A1 Desoxypeganine transdermal therapeutic system
08/24/2000WO2000048576A1 Stereocomplex hydrogels
08/24/2000WO2000048572A1 Phosphocholine linked prodrug derivatives
08/24/2000WO2000048571A1 Spontaneously dispersible n-benzoyl staurosporine compositions
08/24/2000WO2000048570A1 Pharmaceutical composition for balanic transmucosal administration of alfuzosin
08/24/2000WO2000048566A1 Skin preparations for external use
08/24/2000WO2000048558A1 Modified calycins
08/24/2000WO2000048551A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
08/24/2000WO2000048475A1 Masking agent
08/24/2000WO2000032205A8 Immunomodulatory methods using carbohydrate antigens
08/24/2000WO2000024362A3 Δ9 tetrahydrocannabinol (δ9 thc) solution metered dose inhalers and methods of use
08/24/2000WO2000022112A9 Stabilized bioactive peptides and methods of identification, synthesis and use
08/24/2000WO2000021569A3 Macromolecular active substance conjugates and a method for the production thereof
08/24/2000WO2000018440A8 Somatostatin receptor radioligand with increased uptake
08/24/2000WO2000016818A9 Functionalized derivatives of hyaluronic acid and formation of hydrogels in situ using same
08/24/2000WO2000010611A3 Drug targeting
08/24/2000WO2000010536A9 Extended release buccal bioadhesive tablet
08/24/2000WO2000006194A3 Depletion of cells responsible for antibody-mediated graft rejection
08/24/2000DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs
08/24/2000CA2634674A1 Novel albumin-free factor viii formulations
08/24/2000CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas
08/24/2000CA2371872A1 Methods and compositions for regulating protein-protein interactions
08/24/2000CA2368537A1 Combinations of formoterol and fluticasone propionate for asthma
08/24/2000CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy
08/24/2000CA2362807A1 Multi-mutant diphtheria toxin vaccines
08/24/2000CA2362355A1 Effervescent laxatives
08/24/2000CA2362346A1 Natural antioxidant compositions, method for obtaining same and cosmetic, pharmaceutical and nutritional formulations thereof
08/24/2000CA2362284A1 Modified calycins
08/24/2000CA2362227A1 Masking agent comprising salt of gluconic acid
08/24/2000CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response
08/24/2000CA2299117A1 Antimycotic compositions
08/23/2000EP1029892A1 Freeze-dried polysaccharide-especially paramylon containing agent, its preparation and use
1 ... 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 ... 1712